I already mentioned the hep b/ccr5 connection from request of aidenb, but here is hep c article just out this week. Of course leronlimab wasn't used, one it gets approval, that changes or maybe when the HIV cure in monkeys paper is published using leronlimab. I suspect that bring in big interest in the hiv community. Cancer data seems to be coming back great. The pendulum will swing the other way. There will come a day of reckoning imo between our share price and the potential we are seeing everywhere in research.

https://www.ncbi.nlm.nih.gov/pubmed/31661521

CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro